Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
betaine aldehyde + phenazine methosulfate
glycine-betaine + ?
-
Substrates: -
Products: -
?
choline + 2 acceptor + H2O
glycine-betaine + 2 reduced acceptor + H+
choline + 2,6-dichlorophenolindophenol
betaine aldehyde + reduced 2,6-dichlorophenolindophenol
-
Substrates: -
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
choline + acceptor + phenazine methosulfate
betaine aldehyde + ?
-
Substrates: -
Products: -
?
choline + coenzyme Q1
betaine aldehyde + reduced coenzyme Q1
-
Substrates: mitochondrial oxidation of choline
Products: -
?
choline + p-benzoquinone
betaine aldehyde + reduced p-benzoquinone
-
Substrates: -
Products: -
r
choline + phenazine methosulfate
betaine aldehyde + reduced phenazine methosulfate
additional information
?
-
choline + 2 acceptor + H2O
glycine-betaine + 2 reduced acceptor + H+
-
Substrates: four electron oxidation with betaine aldehyde as intermediate, provides glycine-betaine as compatible solute
Products: -
?
choline + 2 acceptor + H2O
glycine-betaine + 2 reduced acceptor + H+
-
Substrates: four electron oxidation with betaine aldehyde as intermediate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: 2,6-dichlorophenolindophenol
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: choline is the sole substrate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: -
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: relation of plasma choline and betaine to cardiovascular risk factors, mitochondrial choline dehydrogenase pathway
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: effects of food-deprivation on betaine accumulation and the levels of betaine synthesizing enzymes
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: -
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor 3-(4,5-dimethylthiazolyl-2-)-2,5-diphenyltetrazolium bromide, particulate enzyme: 12.4% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: cytochrome c, particulate enzyme: 3.1% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: 2,6-dichlorophenolindophenol
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor ferricyanide, particulate enzyme: 112% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor 2,6-dichlorophenolindophenol, particulate enzyme: 3.2% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor: phenazine methosulfate, 100% relative activity
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor 3-(4,5-dimethylthiazolyl-2-)-2,5-diphenyltetrazolium bromide, particulate enzyme: 12.4% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: cytochrome c, particulate enzyme: 3.1% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor ferricyanide, particulate enzyme: 112% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor 2,6-dichlorophenolindophenol, particulate enzyme: 3.2% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor: phenazine methosulfate, 100% relative activity
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: -
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: -
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor: ubiquinone-2
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: the enzyme can use only choline and betaine aldehyde
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor O2: 73% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: 2,6-dichlorophenolindophenol
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor 2,6-dichlorophenolindophenol: 27% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: absolute requirement for an electron acceptor other than O2
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: reverse reaction at 5.2% of forward reaction
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: cytochrome c, ferricyanide, methylene blue and 2,6-dichlorophenolindophenol show no direct reaction with the enzyme
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor methylene blue: 4% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: coenzyme Q, primary electron acceptor in vivo
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor cytochrome c: 63% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor: phenazine methosulfate, 100% relative activity
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: phenazine methosulfate
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: not: 2-dimethylaminoethanol, monoethanolamine
Products: -
r
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: electron acceptor: p-benzoquinone
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
-
Substrates: acceptor ferricyanide: 42% relative activity to phenazine methosulfate
Products: -
?
choline + acceptor
betaine aldehyde + reduced acceptor
Substrates: connects choline to the respiratory chain
Products: -
?
choline + phenazine methosulfate
betaine aldehyde + reduced phenazine methosulfate
Substrates: -
Products: -
?
choline + phenazine methosulfate
betaine aldehyde + reduced phenazine methosulfate
Substrates: -
Products: -
?
choline + phenazine methosulfate
betaine aldehyde + reduced phenazine methosulfate
Substrates: -
Products: -
?
choline + phenazine methosulfate
betaine aldehyde + reduced phenazine methosulfate
-
Substrates: -
Products: -
r
choline + phenazine methosulfate
betaine aldehyde + reduced phenazine methosulfate
-
Substrates: -
Products: -
r
additional information
?
-
-
Substrates: the enzyme is responsible for the two-step choline oxidation to betaine together with the betaine-homocysteine methyltransferase
Products: -
?
additional information
?
-
Substrates: the enzyme is specific for choline or betaine aldehyde as substrate, substrate specificity, overview
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Alzheimer Disease
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Amyotrophic Lateral Sclerosis
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Breast Neoplasms
Choline dehydrogenase polymorphism rs12676 is a functional variation and is associated with changes in human sperm cell function.
Breast Neoplasms
Choline metabolism and risk of breast cancer in a population-based study.
Breast Neoplasms
Dietary choline and betaine intake, choline-metabolising genetic polymorphisms and breast cancer risk: a case-control study in China.
Breast Neoplasms
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
Breast Neoplasms
The Prognostic Biomarkers HOXB13, IL17BR, and CHDH Are Regulated by Estrogen in Breast Cancer.
Choline Deficiency
Choline dehydrogenase polymorphism rs12676 is a functional variation and is associated with changes in human sperm cell function.
Choline Deficiency
Common genetic polymorphisms affect the human requirement for the nutrient choline.
Coronary Artery Disease
Cystathionine beta-synthase 844Ins68 polymorphism is not associated with the levels of homocysteine and cysteine in an Indian population.
Endometriosis
Polymorphic variants of folate and choline metabolism genes and the risk of endometriosis-associated infertility.
Fetal Death
Polymorphic variants of genes involved in choline pathway and the risk of intrauterine fetal death.
Frontotemporal Dementia
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Hyperhomocysteinemia
Single nucleotide polymorphisms in homocysteine metabolism pathway genes: association of CHDH A119C and MTHFR C677T with hyperhomocysteinemia.
Hypernatremia
Renal inner medullary choline dehydrogenase activity: characterization and modulation.
Metabolic Syndrome
Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women.
Neoplasms
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
Neoplasms
The Prognostic Biomarkers HOXB13, IL17BR, and CHDH Are Regulated by Estrogen in Breast Cancer.
Obesity
CHDH-PNPLA3 Gene-Gene Interactions Predict Insulin Resistance in Children with Obesity.
Pancreatic Neoplasms
The role of the folate pathway in pancreatic cancer risk.
Parkinson Disease
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Pulmonary Disease, Chronic Obstructive
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Squamous Cell Carcinoma of Head and Neck
A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.
Starvation
The accumulation and synthesis of betaine in winter skate (Leucoraja ocellata).
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.